Each 500 mg. capsule contains:

   
    Composition:

Vasa (Adhatoda vasica).......................................................65 mg

Tulsi (Ocimum santum).......................................................25 mg

Jambolan (Eugenia Jambolane).......................................25 mg

Ginger (Zingiber officibale)..................................................25 mg

Haridra (Curcuma Longal)...................................................25 mg

Bow rasa (Archetto (musica)................................................25 mg

Halite (Natrium).......................................................................85 mg

Sodium bicarbonate (Natron).............................................125 mg

Mangnesium stearate (Dryer)....................................................q.s.

Indications:

Useful in all kinds of anemic diseases.

Description:

The leaves of the vasa plant contain the alkaloid vasicine (C11H12N2O), which is responsible for the small but persistent bronchodilatation, and an essential oil which is chiefly responsible for the expectorant action. The leaves and roots contain other alkaloids, vasicinone, vasicinolone and vasicol, which may contribute to the bronchodilatory effect through anticholinergic action on the vagal innervation of the bronchii. The bronchodilation effect is considerably increased after atropine administration. Studies have also shown vasa to be effective in the treatment of amlapitta (dyspepsia) and pyorrhea . The in vitro growth of several strains of Mycoplasma tuberculosis was inhibited by the essential oil at concentrations in the range of 2-20 ug/ml. . There has also been a report of thrombopoetic (platelet-increasing) activity with vasicine.
Tulasi leaf powder was fed at the 1% level in normal and diabetic rats for a period of one month to explore the effect on fasting blood sugar, uronic acid, total amino acids, and the lipid profile in serum and tissue lipids. The results indicated a significant reduction in fasting blood sugar, uronic acid, total amino acids, total cholesterol, triglyceride, phospholipids and total lipids. In liver, total cholesterol, triglyceride and total lipids were significantly lowered. Total lipids were significantly reduced in kidney. In heart, a significant fall in total cholesterol and phospholipids was observed. All these observations indicate the hypoglycemic and hypolipidemic effect of Tulasi in diabetic rats.

Dosage:

2 capsules 3 times a day or as directed by the Physician

Presentations:  90 Caps.    

                                 MRP              Retailer              Stockiest

                            360.00             288.00                  259.20